Recent findings have shown that NPC1L1 deficiency or NPC1L1 inhibition reduces blood cholesterol and prevents hepatic steatosis and diet-induced obesity [50]. This evidence concerns the gene NPC1L1 and obesity due to melanocortin 4 receptor deficiency.